TG Therapeutics | TGTX - Market Capitalization


TG Therapeutics reported $8.28B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Alaunos Therapeutics USD 46M 39M Jun/2026
Amgen USD 189.89B 13.64B Mar/2026
Arrowhead Research USD 8.78B 236M Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Corcept Therapeutics USD 4.32B 654M Mar/2026
Curis USD 3M 10M Jun/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 1.05B 912M Jun/2026
Novartis USD 307.76B 15.54B Mar/2026
Novavax USD 1.09B 316M Dec/2025
PTC Therapeutics USD 5.64B 460M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 5.31B 572M Mar/2026
Verastem USD 110M 486M Jun/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026